One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...

Ventripoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF) is building a subscription business around technology that converts standard 2D ultrasound images into detailed 3D heart models with MRI-level ...

EEG-based machine learning predicted SSRI treatment response in depression with high accuracy. Learn how brain signals could ...

Imagine the final stages of an audit engagement are due in the next few days. During this concluding phase, you anxiously await forthcoming review points from the engagement quality (EQ) reviewer. The ...

Artificial Intelligence - Catch up on select AI news and developments from the past week or so. Stay in the know.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Using a superconducting quantum computer, physicists created a large and complex version of an odd quantum material that has ...

When overly complex operations hinder performance and progress, organizations can strategically use AI to ensure their ...

Economist Peter Schiff questioned on Thursday how Strategy Inc. (NASDAQ:MSTR) can sustain the 11% dividend payout on its ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...